معرفی
Alejandro Gomez Toledo is a Researcher at the Department of Infection Medicine, Lund University's Faculty of Medicine, and part of the Biomedical Center (BMC) Proteomics group. His work aligns with the UN Sustainable Development Goal 3 (Good Health and Well-being).
His research focuses on:
- Infectious Diseases (Staphylococcus aureus, Streptococcus Group A)
- Immunology (Monoclonal Antibodies, Antigen-Antibody Complexes)
- Proteomics and Glycobiology (Glycan, Cell Surface)
- Molecular Biology (Structural Modeling, Systems Biology)
- Biotechnology (Gene Editing, Metabolic Engineering)
Recent publications highlight his contributions to understanding endothelial glycocalyx turnover in vascular diseases, developing antigenomics-serology workflows for pathogen immunity, and innovating multiplex genome editing to control lactate metabolism. His work bridges Immunology, Biochemistry, and Genetics, with subfields like epitope mapping, metabolic pathways, and structural modeling.
He collaborates internationally and has co-authored articles with researchers such as J. Malmström and N. E. Lewis. His studies are published in journals like Nature Communications, Annual Review of Biochemistry, and Nature Metabolism, with preprints on platforms like bioRxiv. His findings have been disseminated by 10 news outlets and referenced on social media (X, Bluesky).
At the BMC Proteomics group, he applies XL-MS and computational modeling to study pathogen-host interactions and metabolic networks. His research impacts vascular pathology, infectious disease diagnostics, and biotechnological applications in cell culture optimization.
